Chevron Corporation
Chevron Corporation (CVX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Chevron Corporation (CVX), covering cash flow, earnings, and balance sheets.
Chevron Corporation (CVX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Chevron Corporation CVX financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $47.61B | $48.33B | $48.93B | $49.57B |
Cost of Revenue | $36.25B | $35.12B | $34.66B | $34.87B |
Gross Profit | $11.36B | $13.21B | $14.26B | $14.70B |
Gross Profit Ratio | $0.24 | $0.27 | $0.29 | $0.30 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $1.58B | $1.19B | $1.05B |
Operating Expenses | $13.21B | $10.80B | $9.30B | $9.11B |
Total Costs & Expenses | $49.45B | $45.92B | $43.97B | $43.98B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $212.00M | $199.00M | $164.00M | $113.00M |
Depreciation & Amortization | $4.12B | $5.18B | $4.23B | $4.18B |
EBITDA | $9.92B | $11.44B | $10.88B | $11.33B |
EBITDA Ratio | $0.21 | $0.24 | $0.22 | $0.23 |
Operating Income | -$1.84B | $2.42B | $4.96B | $5.59B |
Operating Income Ratio | -$0.04 | $0.05 | $0.10 | $0.11 |
Other Income/Expenses (Net) | $7.43B | $3.64B | $1.53B | $1.45B |
Income Before Tax | $5.58B | $6.06B | $6.49B | $7.04B |
Income Before Tax Ratio | $0.12 | $0.13 | $0.13 | $0.14 |
Income Tax Expense | $2.07B | $2.80B | $1.99B | $2.59B |
Net Income | $3.51B | $3.24B | $4.49B | $4.43B |
Net Income Ratio | $0.07 | $0.07 | $0.09 | $0.09 |
EPS | $2.01 | $1.83 | $2.49 | $2.43 |
Diluted EPS | $2.01 | $1.82 | $2.48 | $2.43 |
Weighted Avg Shares Outstanding | $1.74B | $1.77B | $1.80B | $1.83B |
Weighted Avg Shares Outstanding (Diluted) | $1.75B | $1.78B | $1.81B | $1.83B |
Over the past four quarters, Chevron Corporation demonstrated steady revenue growth, increasing from $49.57B in Q2 2024 to $47.61B in Q1 2025. Operating income reached -$1.84B in Q1 2025, maintaining a consistent -4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $9.92B, reflecting operational efficiency. Net income rose to $3.51B, with EPS at $2.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan